Amit Nilkanth Patel is an Indian-American cardiac surgeon and former director of clinical regenerative medicine and tissue engineering at the University of Utah in Salt Lake City.
[2][3] He is currently the national lead investigator for Aastrom Biosciences, now Vericel Corp, to treat both ischemic and non-ischemic cardiomyopathy by using adult stem cells.
He is also the lead investigator for several trials to use adult stem cells to treat limb ischemia (inadequate blood flow to the leg).
[4][5] He is currently working on programs for type 2 diabetes, burn wound therapies with the U.S. military & arteriocyte, traumatic brain injury, and plastic reconstruction.
Patel was involved in a retracted study, authored by Mandeep R. Mehra and Sapan Desai, relating to using hydroxychloroquine to treat COVID-19 during the COVID-19 pandemic, which used suspect data from Surgisphere.